Nektar Therapeutics (BMV:NKTR)
543.00
+129.00 (31.16%)
At close: Aug 28, 2025
Nektar Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 42.99 | 44.25 | 35.28 | 88.23 | 25.22 | 198.96 | Upgrade |
Short-Term Investments | 132.92 | 210.97 | 268.34 | 416.75 | 708.74 | 862.94 | Upgrade |
Cash & Short-Term Investments | 175.9 | 255.23 | 303.62 | 504.98 | 733.96 | 1,062 | Upgrade |
Cash Growth | -35.15% | -15.94% | -39.88% | -31.20% | -30.88% | -19.85% | Upgrade |
Accounts Receivable | - | - | 1.21 | 5.98 | 22.49 | 38.89 | Upgrade |
Inventory | - | - | 16.1 | 19.2 | 15.8 | 15.29 | Upgrade |
Other Current Assets | 10.66 | 6.07 | 9.78 | 15.81 | 23.33 | 21.93 | Upgrade |
Total Current Assets | 186.57 | 261.29 | 330.7 | 545.97 | 795.58 | 1,138 | Upgrade |
Net Property, Plant & Equipment | 10.57 | 11.82 | 36.86 | 85.89 | 177.54 | 186.14 | Upgrade |
Goodwill | - | - | - | 76.5 | 76.5 | 76.5 | Upgrade |
Long-Term Investments | 5.37 | 26.09 | 25.83 | - | 64.83 | 136.66 | Upgrade |
Other Long-Term Assets | 5.02 | 4.65 | 4.64 | 2.25 | 2.74 | 1.46 | Upgrade |
Total Assets | 207.53 | 303.85 | 398.03 | 710.6 | 1,117 | 1,539 | Upgrade |
Accounts Payable | 14.28 | 11.56 | 9.85 | 12.98 | 9.75 | 22.14 | Upgrade |
Accrued Expenses | 35.1 | 29.97 | 22.16 | 36.56 | 58.01 | 79.73 | Upgrade |
Current Portion of Leases | 22.01 | 19.87 | 19.26 | 18.67 | 17.44 | 13.92 | Upgrade |
Total Current Liabilities | 71.39 | 61.4 | 51.27 | 68.2 | 85.2 | 115.78 | Upgrade |
Long-Term Leases | 74.15 | 82.7 | 98.52 | 112.83 | 125.74 | 136.37 | Upgrade |
Other Long-Term Liabilities | 86.21 | 99.02 | 117.26 | 162.93 | 226.75 | 209.32 | Upgrade |
Total Long-Term Liabilities | 160.35 | 181.71 | 215.78 | 275.76 | 352.48 | 345.69 | Upgrade |
Total Liabilities | 231.75 | 243.11 | 267.05 | 343.96 | 437.68 | 461.47 | Upgrade |
Common Stock | 0 | 0 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade |
Treasury Stock | -3 | -3 | - | - | - | - | Upgrade |
Additional Paid-in Capital | 3,667 | 3,660 | 3,608 | 3,575 | 3,517 | 3,389 | Upgrade |
Accumulated Other Comprehensive Income | -0.01 | 0.06 | 0.08 | -6.91 | -4.16 | -2.3 | Upgrade |
Retained Earnings | -3,689 | -3,596 | -3,477 | -3,201 | -2,833 | -2,309 | Upgrade |
Shareholders' Equity | -24.21 | 60.74 | 130.99 | 366.64 | 679.51 | 1,077 | Upgrade |
Total Liabilities & Equity | 207.53 | 303.85 | 398.03 | 710.6 | 1,117 | 1,539 | Upgrade |
Total Debt | 96.16 | 102.56 | 117.78 | 131.5 | 143.18 | 150.29 | Upgrade |
Net Cash (Debt) | 79.75 | 152.66 | 185.84 | 373.48 | 590.78 | 911.61 | Upgrade |
Net Cash Growth | -47.76% | -17.85% | -50.24% | -36.78% | -35.19% | -0.56% | Upgrade |
Net Cash Per Share | 5.69 | 11.13 | 14.67 | 29.94 | 48.35 | 76.57 | Upgrade |
Book Value | -24.21 | 60.74 | 130.99 | 366.64 | 679.51 | 1,077 | Upgrade |
Book Value Per Share | -1.73 | 4.43 | 10.34 | 29.39 | 55.61 | 90.49 | Upgrade |
Tangible Book Value | -24.21 | 60.74 | 130.99 | 290.14 | 603.01 | 1,001 | Upgrade |
Tangible Book Value Per Share | -1.73 | 4.43 | 10.34 | 23.26 | 49.35 | 84.06 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.